Development of Paroxetine Hydrochloride Single Layer Controlled-Release Tablets Based on 3² Factorial Design.

Yang, Yao; Huang, Zhengwei; Zhang, Xuan; Li, Jinyuan; Huang, Ying; Chen, Wanxin; Pan, Xin; Wu, Chuanbin

Yang, Yao; Huang, Zhengwei; Zhang, Xuan; Li, Jinyuan; Huang, Ying; Chen, Wanxin; Pan, Xin; Wu, Chuanbin.

Afiliação

Yang Y; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. yangyao5@mail2.sysu.edu.cn.
Huang Z; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. hzhengw3@mail2.sysu.edu.cn.
Zhang X; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. zhangx57@mail2.sysu.edu.cn.
Li J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China. lijiny@sysucc.org.cn.
Huang Y; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. huangying3@mail.sysu.edu.cn.
Chen W; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. chenwx49@mail2.sysu.edu.cn.
Pan X; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. panxin2@mail.sysu.edu.cn.
Wu C; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. wuchuanb@mail.sysu.edu.cn.

Pharmaceutics ; 10(4)2018 Nov 20.

Article em En | MEDLINE | ID: mdl-30463329

Palavras-chave

PAXIL® CR; depressive disorder; factorial design; oral bioavailability; paroxetine hydrochloride; single layer controlled-release tablet

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceutics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google